Tetanus–diphtheria–acellular pertussis vaccination of adults in the USA

References

• Hewlett EL. A commentary on the pathogenesis of pertussis. Clin. Infect. Dis.2(Suppl. 2), S94–S98 (1999).
   Google Scholar
• Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, Demmler GJ, Kaplan S (Eds). WB Saunders, PA, USA 1588–1608 (2004).
   Google Scholar
• Heininger U, Stehr K, Schmitt-Grohe S et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J.13(4), 306–309 (1994).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Pertussis – United States, 1997–2000. MMWR Morb. Mortal. Wkly Rep.51(4), 73–76 (2002).
   PubMedGoogle Scholar
• Guris D, Strebel PM, Bardenheier B et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin. Infect. Dis.28(6), 1230–1237 (1999).
   PubMed Web of Science ®Google Scholar
• Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980–1989. Clin. Infect. Dis.14(3), 708–719 (1992).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Pertussis – United States, 2001–2003. MMWR Morb. Mortal. Wkly Rep.54(50), 1283–1286 (2005).
   PubMedGoogle Scholar
• Andrews R, Herceg A, Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun. Dis. Intell.21(11), 145–148 (1997).
   PubMedGoogle Scholar
• De Serres G, Boulianne N, Douville Fradet M, Duval B. pertussis in Quebec: ongoing epidemic since the late 1980s. Can. Commun. Dis. Rep.21(5), 45–48 (1995).
   PubMedGoogle Scholar
• de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerging Infect. Dis.6(4), 348–357 (2000).
   PubMed Web of Science ®Google Scholar
• Annual summary 1979: reported morbidity and mortality in the United States. MMWR Morb. Mortal. Wkly Rep.28, 12–17 (1980).
   Google Scholar
• Jajosky RA, Hall PA, Adams DA et al. Summary of notifiable diseases – United States, 2004. MMWR Morb. Mortal. Wkly Rep.53(53), 1–79 (2006).
   PubMedGoogle Scholar
• McNabb SJ, Jajosky RA, Hall-Baker PA et al. Summary of notifiable diseases – United States, 2005. MMWR Morb. Mortal. Wkly Rep.54(53), 1–92 (2007).
   PubMedGoogle Scholar
• Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet1(8273), 666–669 (1982).
   PubMed Web of Science ®Google Scholar
• Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis.28(Suppl. 2), S112–S117 (1999).
   PubMed Web of Science ®Google Scholar
• Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980–1999. JAMA290(22), 2968–2975 (2003).
   PubMed Web of Science ®Google Scholar
• Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA298(18), 2155–2163 (2007).
   PubMed Web of Science ®Google Scholar
• Baughman AL, Bisgard KM, Edwards KM et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol.11(6), 1045–1053 (2004).
   PubMedGoogle Scholar
• Pebody RG, Gay NJ, Giammanco A et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect.133(1), 159–171 (2005).
   PubMed Web of Science ®Google Scholar
• Cortese MM, Baughman AL, Brown K, Srivastava P. A “new age” in pertussis prevention new opportunities through adult vaccination. Am. J. Prev. Med.32(3), 177–185 (2007).
   PubMed Web of Science ®Google Scholar
• Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA275(21), 1672–1674 (1996).
   PubMed Web of Science ®Google Scholar
• Strebel P, Nordin J, Edwards K et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J. Infect. Dis.183(9), 1353–1359 (2001).
   PubMed Web of Science ®Google Scholar
• Ward JI, Cherry JD, Chang SJ et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med.353(15), 1555–1563 (2005).
   PubMed Web of Science ®Google Scholar
• Mink CM, Cherry JD, Christenson P et al. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis.14(2), 464–471 (1992).
   PubMed Web of Science ®Google Scholar
• Cherry JD. The science and fiction of the “resurgence” of pertussis. Pediatrics112(2), 405–406 (2003).
   PubMed Web of Science ®Google Scholar
• Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J. Infect. Dis.182(5), 1409–1416 (2000).
   PubMed Web of Science ®Google Scholar
• Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr. Infect. Dis. J.22(7), 628–634 (2003).
   PubMed Web of Science ®Google Scholar
• Tindberg Y, Blennow M, Granstrom M. A ten year follow-up after immunization with a two component acellular pertussis vaccine. Pediatr. Infect. Dis. J.18(4), 361–365 (1999).
   PubMedGoogle Scholar
• Lugauer S, Heininger U, Cherry JD, Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur. J. Pediatr.161(3), 142–146 (2002).
   PubMed Web of Science ®Google Scholar
• Simondon F, Preziosi MP, Yam A et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine15(15), 1606–1612 (1997).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J.24(5 Suppl.), S58–S61 (2005).
   PubMedGoogle Scholar
• Aguas R, Goncalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect. Dis.6(2), 112–117 (2006).
   PubMed Web of Science ®Google Scholar
• Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr. Infect. Dis. J.13(5), 343–345 (1994).
   PubMed Web of Science ®Google Scholar
• Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerging Infect. Dis.7(3 Suppl.), 526–528 (2001).
   PubMed Web of Science ®Google Scholar
• Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J. Clin. Microbiol.42(12), 5453–5457 (2004).
   PubMed Web of Science ®Google Scholar
• Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol. Infect.132(2), 185–193 (2004).
   PubMed Web of Science ®Google Scholar
• Fiett J, Letowska I, Gniadkowski M, Hryniewicz W. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J. Microbiol. Methods55(3), 651–666 (2003).
   PubMed Web of Science ®Google Scholar
• Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935–1999. J. Infect. Dis.182(5), 1402–1408 (2000).
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Rhodes P, Connelly BL et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001. Pediatrics116(2), E285–E294 (2005).
   PubMed Web of Science ®Google Scholar
• Byrne S, Slack AT. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003. BMC Infect. Dis.6(53), 53 (2006).
   PubMed Web of Science ®Google Scholar
• Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol.39(12), 4396–4403 (2001).
   PubMed Web of Science ®Google Scholar
• Hardwick TH, Cassiday P, Weyant RS, Bisgard KM, Sanden GN. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerging Infect. Dis.8(1), 44–49 (2002).
   PubMed Web of Science ®Google Scholar
• WHO. Pertussis vaccines – WHO position paper. Wkly Epidemiol. Rec.80(4), 31–39 (2005).
   PubMedGoogle Scholar
• Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr. Infect. Dis. J.24(5 Suppl.), S10–S18 (2005).
   PubMed Web of Science ®Google Scholar
• Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet346(8986), 1326–1329 (1995).
   PubMed Web of Science ®Google Scholar
• Wirsing von Konig CH, Postels-Multani S, Bogaerts H et al. Factors influencing the spread of pertussis in households. Eur. J. Pediatr.157(5), 391–394 (1998).
   PubMedGoogle Scholar
• Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Dis.161(3), 480–486 (1990).
   PubMed Web of Science ®Google Scholar
• De Serres G, Shadmani R, Duval B et al. Morbidity of pertussis in adolescents and adults. J. Infect. Dis.182(1), 174–179 (2000).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Njamkepo E, Bourillon A et al. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J.26(4), 293–299 (2007).
   PubMed Web of Science ®Google Scholar
• Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J.24(5 Suppl.), S19–S24 (2005).
   PubMedGoogle Scholar
• Crowcroft NS, Booy R, Harrison T et al. Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child.88(9), 802–806 (2003).
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J.23(11), 985–989 (2004).
   PubMed Web of Science ®Google Scholar
• Baron S, Njamkepo E, Grimprel E et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J.17(5), 412–418 (1998).
   PubMed Web of Science ®Google Scholar
• Kowalzik F, Barbosa AP, Fernandes VR et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr. Infect. Dis. J.26(3), 238–242 (2007).
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Kenyon TA, Strebel PM, Baughman AL, Shulman ST, Wharton M. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin. Infect. Dis.22(3), 503–507 (1996).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg. Themes Epidemiol.4, 15 (2007).
   PubMedGoogle Scholar
• Gehanno JF, Pestel-Caron M, Nouvellon M, Caillard JF. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect. Control Hosp. Epidemiol.20(8), 549–552 (1999).
   PubMed Web of Science ®Google Scholar
• Bryant KA, Humbaugh K, Brothers K et al. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect. Control Hosp. Epidemiol.27(6), 541–545 (2006).
   PubMed Web of Science ®Google Scholar
• Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect. Control Hosp. Epidemiol.25(11), 995–997 (2004).
   PubMedGoogle Scholar
• Lee GM, Lett S, Schauer S et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin. Infect. Dis.39(11), 1572–1580 (2004).
   PubMed Web of Science ®Google Scholar
• von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect. Dis.2(12), 744–750 (2002).
   PubMed Web of Science ®Google Scholar
• Fatal case of unsuspected pertussis diagnosed from a blood culture – Minnesota, 2003. MMWR Morb. Mortal. Wkly Rep.53(6), 131–132 (2004).
   PubMedGoogle Scholar
• Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol.31(1), 50–52 (1993).
   PubMed Web of Science ®Google Scholar
• Wadowsky RM, Laus S, Libert T, States SJ, Ehrlich GD. Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab. J. Clin. Microbiol.32(4), 1054–1057 (1994).
   PubMed Web of Science ®Google Scholar
• Cloud JL, Hymas W, Carroll KC. Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. J. Clin. Microbiol.40(10), 3838–3840 (2002).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Pertussis (whooping cough). In: Red Book: 2006 Report of the Committee on Infectious Diseases (26th Edition). Pickering LK (Ed.). American Academy of Pediatrics, IL, USA 498–520 (2006).
   Google Scholar
• Hallander HO. Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis.28(Suppl. 2), S99–S106 (1999).
   PubMed Web of Science ®Google Scholar
• Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin. Vaccine Immunol.15(1), 106–114 (2008).
   PubMedGoogle Scholar
• Sloan LM, Hopkins MK, Mitchell PS et al. Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J. Clin. Microbiol.40(1), 96–100 (2002).
   PubMed Web of Science ®Google Scholar
• Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics105(3), E31 (2000).
   PubMed Web of Science ®Google Scholar
• Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J. Clin. Microbiol.37(9), 2872–2876 (1999).
   PubMed Web of Science ®Google Scholar
• Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect. Dis.6, 62 (2006).
   PubMed Web of Science ®Google Scholar
• Lingappa JR, Lawrence W, West-Keefe S, Gautom R, Cookson BT. Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization. J. Clin. Microbiol.40(8), 2908–2912 (2002).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Outbreaks of respiratory illness mistakenly attributed to pertussis – New Hampshire, Massachusetts, and Tennessee, 2004–2006. MMWR Morb. Mortal. Wkly Rep.56(33), 837–842 (2007).
   PubMedGoogle Scholar
• Lievano FA, Reynolds MA, Waring AL et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J. Clin. Microbiol.40(8), 2801–2805 (2002).
   PubMed Web of Science ®Google Scholar
• Ewanowich CA, Chui LW, Paranchych MG, Peppler MS, Marusyk RG, Albritton WL. Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J. Clin. Microbiol.31(7), 1715–1725 (1993).
   PubMed Web of Science ®Google Scholar
• Marchant CD, Loughlin AM, Lett SM et al. Pertussis in Massachusetts, 1981–1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis.169(6), 1297–1305 (1994).
   PubMed Web of Science ®Google Scholar
• Kosters K, Riffelmann M, Dohrn B, von Konig CH. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Clin. Diagn. Lab. Immunol.7(3), 422–426 (2000).
   PubMedGoogle Scholar
• Hewlett EL. Bordetella species. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds). Elsevier, PA, USA (2005).
   Google Scholar
• Tiwari T, Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines. MMWR Recomm. Rep.54(RR-14), 1–16 (2005).
   PubMedGoogle Scholar
• Langley JM, Halperin SA, Boucher FD, Smith B. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics114(1), E96–E101 (2004).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Hoeger WJ, Casey JR. Azithromycin for the treatment of pertussis. Pediatr. Infect. Dis. J.22(9), 847–849 (2003).
   PubMedGoogle Scholar
• Bace A, Zrnic T, Begovac J, Kuzmanovic N, Culig J. Short-term treatment of pertussis with azithromycin in infants and young children. Eur. J. Clin. Microbiol. Infect. Dis.18(4), 296–298 (1999).
   PubMedGoogle Scholar
• Aoyama T, Sunakawa K, Iwata S, Takeuchi Y, Fujii R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J. Pediatr.129(5), 761–764 (1996).
   PubMedGoogle Scholar
• Lebel MH, Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr. Infect. Dis. J.20(12), 1149–1154 (2001).
   PubMedGoogle Scholar
• Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.46(RR-7), 1–25 (1997).
   PubMedGoogle Scholar
• Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet367(9526), 1926–1936 (2006).
   PubMed Web of Science ®Google Scholar
• Broder KR, Cortese MM, Iskander JK et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-3), 1–34 (2006).
   PubMedGoogle Scholar
• Kretsinger K, Broder KR, Cortese MM et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep.55(RR-17), 1–37 (2006).
   PubMedGoogle Scholar
• Pichichero ME, DeTora LM, Johnson DR. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Expert Rev. Vaccines5(2), 175–187 (2006).
   PubMed Web of Science ®Google Scholar
• Rothstein EP, Anderson EL, Decker MD et al. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine17(23–24), 2999–3006 (1999).
   PubMedGoogle Scholar
• Turnbull FM, Heath TC, Jalaludin BB, Burgess MA, Ramalho AC. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria–tetanus vaccine (Td) in adults. Vaccine19(6), 628–636 (2000).
   PubMed Web of Science ®Google Scholar
• Van der Wielen M, Van Damme P, Joossens E, Francois G, Meurice F, Ramalho A. A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults. Vaccine18(20), 2075–2082 (2000).
   PubMed Web of Science ®Google Scholar
• Halperin SA, Smith B, Russell M et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine18(14), 1312–1319 (2000).
   PubMed Web of Science ®Google Scholar
• Minh NN, He Q, Ramalho A et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics104(6), E70 (1999).
   PubMedGoogle Scholar
• Halperin SA, Smith B, Russell M et al. Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr. Infect. Dis. J.19(4), 276–283 (2000).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Rennels MB, Edwards KM et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA293(24), 3003–3011 (2005).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics117(4), 1084–1093 (2006).
   PubMedGoogle Scholar
• Decker MD, Edwards KM, Steinhoff MC et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics96(3 Pt 2), 557–566 (1995).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Deloria MA, Rennels MB et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics100(5), 772–788 (1997).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Edwards KM, Anderson EL et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics105(1), E11 (2000).
   PubMed Web of Science ®Google Scholar
• Woo EJ, Burwen DR, Gatumu SN, Ball R. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin. Infect. Dis.37(3), 351–358 (2003).
   PubMed Web of Science ®Google Scholar
• Rennels MB, Deloria MA, Pichichero ME et al. Extensive swelling after booster doses of acellular pertussis–tetanus–diphtheria vaccines. Pediatrics105(1), E12 (2000).
   PubMed Web of Science ®Google Scholar
• Schmitt HJ, Beutel K, Schuind A et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. J. Pediatr.130(4), 616–623 (1997).
   PubMed Web of Science ®Google Scholar
• Halperin SA, Sweet L, Baxendale D et al. How soon after a prior tetanus–diphtheria vaccination can one give adult formulation tetanus–diphtheria–acellular pertussis vaccine? Pediatr. Infect. Dis. J.25(3), 195–200 (2006).
   PubMed Web of Science ®Google Scholar
• Adverse events after vaccination with dTap in high school students who have previously been vaccinated with d2T5. Can. Commun. Dis. Rep.32(3), 25–28 (2006).
   PubMedGoogle Scholar
• David ST, Hemsley C, Pasquali PE, Larke B, Buxton JA Lior LY. Enhanced surveillance for vaccine-associated adverse events: dTap catch-up of high school students in Yukon. Can. Commun. Dis. Rep.31(11), 117–126 (2005).
   PubMedGoogle Scholar
• Talbot EA, Brown K, Kirkland K et al. Safety of mass immunization with tetanus–diphtheria–acellular pertussis vaccine (Tdap) during a NH hospital pertussis outbreak. Presented at: The 44th Annual Meeting of the Infectious Diseases Society of America. Toronto, ON, Canada, 12–15 October 2006.
   Google Scholar
• Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-15), 1–48 (2006).
   PubMedGoogle Scholar
• Pichichero ME, Treanor J. Economic impact of pertussis. Arch. Pediatr. Adolesc. Med.151(1), 35–40 (1997).
   PubMed Web of Science ®Google Scholar
• Lee LH, Pichichero ME. Costs of illness due to Bordetella pertussis in families. Arch. Fam. Med.9(10), 989–996 (2000).
   PubMedGoogle Scholar
• Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost–benefit analysis. Clin. Infect. Dis.39(1), 20–28 (2004).
   PubMed Web of Science ®Google Scholar
• Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics115(6), 1675–1684 (2005).
   PubMed Web of Science ®Google Scholar
• Lee GM, Murphy TV, Lett S et al. Cost effectiveness of pertussis vaccination in adults. Am. J. Prev. Med.32(3), 186–193 (2007).
   PubMed Web of Science ®Google Scholar
• Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine22(23–24), 3154–3165 (2004).
   PubMed Web of Science ®Google Scholar
• Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine25(14), 2634–2642 (2007).
   PubMed Web of Science ®Google Scholar
• Preziosi MP, Yam A, Wassilak SG et al. Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program. Am. J. Epidemiol.155(10), 891–896 (2002).
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A, Earnest A, Ravindran S, Paton NI. High incidence of pertussis among Hajj pilgrims. Clin. Infect. Dis.37(9), 1270–1272 (2003).
   PubMedGoogle Scholar
• Wilder-Smith A, Boudville I, Earnest A, Heng SL, Bock HL. Knowledge, attitude, and practices with regard to adult pertussis vaccine booster in travelers. J. Travel Med.14(3), 145–150 (2007).
   PubMed Web of Science ®Google Scholar
• Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP). MMWR Recomm. Rep.40(RR-10), 1–28 (1991).
   PubMedGoogle Scholar
• Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr. Infect. Dis. J.24(5 Suppl.), S62–S65 (2005).
   PubMedGoogle Scholar
• Clark SJ, Adolphe S, Davis MM, Cowan AE, Kretsinger K. Attitudes of US obstetricians toward a combined tetanus–diphtheria–acellular pertussis vaccine for adults. Infect. Dis. Obstet. Gynecol. 2006, 87040 (2006).
   PubMedGoogle Scholar
• Davis MM, Kretsinger K, Cowan AE, Stokley S, Clark SJ. New combined tetanus–diptheria–acellular pertussis vaccines for adults: primary care physician attitudes and preferences. Hum. Vaccin.3(4), 130–134 (2007).
   PubMed Web of Science ®Google Scholar